(Q34162846)

31 July 2017

1 reference

title

Definition and classification of cancer cachexia: an international consensus (English)

1 reference

31 July 2017

18

Stein Kaasa

0 references

Paula Ravasco

Paula Ravasco

15

0 references

Declan Walsh

Declan Walsh

16

0 references

Vickie E. Baracos

Vickie E Baracos

19

0 references

Stefan D. Anker

3

Stefan D Anker

1 reference

31 July 2017

5

Eduardo Bruera

1 reference

31 July 2017

0 references

14

Lukas Radbruch

1 reference

31 July 2017

Kenneth Fearon

1

1 reference

31 July 2017

Florian Strasser

2

1 reference

31 July 2017

Ingvar Bosaeus

4

1 reference

31 July 2017

Robin L Fainsinger

6

1 reference

31 July 2017

Aminah Jatoi

7

1 reference

31 July 2017

Charles Loprinzi

8

1 reference

31 July 2017

Neil MacDonald

9

1 reference

31 July 2017

Giovanni Mantovani

10

1 reference

31 July 2017

Mellar Davis

11

1 reference

31 July 2017

Maurizio Muscaritoli

12

1 reference

31 July 2017

Faith Ottery

13

1 reference

31 July 2017

Andrew Wilcock

17

1 reference

31 July 2017

publication date

4 February 2011

1 reference

Lancet Oncology Commission

31 July 2017

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

489-495

1 reference

Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Cachexia worsens prognosis in patients with resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

The views and practice of oncologists towards nutritional support in patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

The prevalence of concern about weight loss and change in eating habits in people with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Cancer cachexia: developing multimodal therapy for a multidimensional problem

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Symptom assessment in palliative care: a need for international collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Systematic review of the treatment of cancer-associated anorexia and weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Nutritional support in multimodal therapy for cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Appraisal of current and experimental approaches to the treatment of cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Mechanisms to explain wasting of muscle and fat in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Why is progress in treatment of cancer cachexia so slow?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Estimation of Cachexia among Cancer Patients Based on Four Definitions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Weight loss in patients with advanced cancer: effects, causes, and potential management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Cachexia: a new definition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Applying the Delphi process to palliative care tool development: lessons learned.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Is Pain Intensity a Predictor of the Complexity of Cancer Pain Management?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Qualitative Research: Introducing focus groups

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

The emerging role of computerized tomography in assessing cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Epidemiology of sarcopenia among the elderly in New Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

The use of artificial nutrition among cancer patients enrolled in palliative home care services

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

A proposed clinical staging system for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

The role of cytokines in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970218-7

7 January 2021

10.1016/S1470-2045(10)70218-7

Identifiers

DOI

1 reference

release_cqgfpiunl5evxmgynldph3cjsa

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cqgfpiunl5evxmgynldph3cjsa

24 November 2022

mapped directly with Wikidata item

1 reference